Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

3 structures for Q9P7Y9

Entry ID Method Resolution Chain Position Source
2RUJ NMR - A 247-400 PDB
2RVK NMR - A 247-400 PDB
AF-Q9P7Y9-F1 Predicted AlphaFoldDB

3 variants for Q9P7Y9

Variant ID(s) Position Change Description Diseaes Association Provenance
I_4747722_A_T 170 L>I No Jeffares_SNPs
I_4747397_A_T 278 F>Y No Jeffares_SNPs
I_4747131_C_A 367 V>L No Jeffares_SNPs

No associated diseases with Q9P7Y9

3 regional properties for Q9P7Y9

Type Name Position InterPro Accession
domain Homeobox domain 122 - 186 IPR001356
conserved_site Homeobox, conserved site 157 - 180 IPR017970
domain Homeobox protein SIX1, N-terminal SD domain 9 - 119 IPR031701

Functions

Description
EC Number
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
TORC2 complex A protein complex that contains at least TOR (target of rapamycin) and Rictor (rapamycin-insensitive companion of TOR), or orthologs of, in complex with other signaling components. Mediates the phosphorylation and activation of PKB (also called AKT). In Saccharomyces, the complex contains Avo1p, Avo2p, Tsc11p, Lst8p, Bit61p, Slm1p, Slm2p, and Tor2p.

2 GO annotations of molecular function

Name Definition
phosphatidylinositol-4,5-bisphosphate binding Binding to phosphatidylinositol-4,5-bisphosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 4' and 5' positions.
signaling adaptor activity The binding activity of a molecule that brings together two or more molecules in a signaling pathway, permitting those molecules to function in a coordinated way. Adaptor molecules themselves do not have catalytic activity.

5 GO annotations of biological process

Name Definition
meiotic cell cycle Progression through the phases of the meiotic cell cycle, in which canonically a cell replicates to produce four offspring with half the chromosomal content of the progenitor cell via two nuclear divisions.
p38MAPK cascade An intracellular protein kinase cascade containing at least a p38 MAPK, a MAPKK and a MAP3K. The cascade can also contain an additional tier: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
positive regulation of conjugation with cellular fusion Any process that increases the rate or frequency of conjugation with cellular fusion.
positive regulation of G2/M transition of mitotic cell cycle Any signalling pathway that activates or increases the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G2 phase to M phase of the mitotic cell cycle.
TORC2 signaling A series of intracellular molecular signals mediated by TORC2; TOR (rapamycin-insensitive companion of TOR) in complex with at least Rictor (regulatory-associated protein of TOR), or orthologs of, and other signaling components.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MELTREKVLL LTFLRMQYSH ILPDSIENRV ISTEAPEWEL DKSLQDLLIH DYDYSKTSFS
70 80 90 100 110 120
SSPPIVANDT VSNVRKPSDT KQVNGAGGQV NHSRAEDSDY ATSDLSESSD VGDDDNSCIF
130 140 150 160 170 180
SFSKVPMQKD VASIKEEERL DPKISTLNNI DAIANLKLTN MVESSQAVNL TSSKQSSINQ
190 200 210 220 230 240
QSSVSTDYDD LRSISEESFH LSQGEIPLTF PMNSSLTDTE ADAVVAVDAL FPGKQRGTHN
250 260 270 280 290 300
TVNKARSVSN AKAPTSALRA LLEHKENSSQ NGPLAENFAT FSGHAESNAL RLNIYFPSSE
310 320 330 340 350 360
SPSKPLFVEL RKNVLVSEAI GYILLQYVNQ QLVPPIEDEA QNPNYWNLRI VEDDGELDED
370 380 390 400 410 420
FPALDRVGPL SKFGFDAFAL VKATPAQIKE NQAAYPFKSK HPTSIPEANN KTHIRHTSST
430 440 450 460 470 480
SSQSQKQAQD VKDTLNTSHV VQVRLPPYGD NARFCNIEIS KTTRLAMVLN QVCWMKQLER
490 500 510 520 530 540
FKYTLRVAGS DTVLPLDKTF SSLDGNPTLE LVKKKVRDKK GSTQQLPTSS PQNSVYGSIK
550 560 570 580 590 600
KDAQSSTYNA TDIMSSNTYQ EFLVWKRQPV SFMGRHERLL AIDGEYVHIM PSESKNIFET
610 620 630 640 650 660
PKTSSIHAGS IILCKQSKKS PCNFKMIVSK NRETKRYDFE VLSALEAAII VSRIRALMNT
VKKIN